Aspire Biopharma Holdings, Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

0.3252

-0.0048 (-1.45%)

At close: May 13, 2025, 4:00 PM

0.3130

-0.0122 (-3.75%)

Pre-market: May 14, 2025, 6:10 AM EDT

Aspire Biopharma Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-0.65	-0.36	-0.6
Change in Accounts Payable	-0.03	0.05	0.1
Change in Other Net Operating Assets	0.28	0.4	0.35
Operating Cash Flow	-0.4	0.09	-0.14
Sale (Purchase) of Intangibles	-0.08	-0.08	-4.9
Investing Cash Flow	-0.08	-0.08	-4.9
Issuance of Common Stock	0.26	-	1
Other Financing Activities	-	-	3.85
Financing Cash Flow	0.48	-	4.85
Net Cash Flow	0	0.01	-0.19
Levered Free Cash Flow	-	-0.26	-
Unlevered Free Cash Flow	-	-0.26	-
Change in Net Working Capital	-	-0.04	-

Updated Jan 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.